1. Home
  2. NOVT vs GRFS Comparison

NOVT vs GRFS Comparison

Compare NOVT & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novanta Inc.

NOVT

Novanta Inc.

HOLD

Current Price

$151.10

Market Cap

4.7B

Sector

Miscellaneous

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.47

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOVT
GRFS
Founded
1968
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.4B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
NOVT
GRFS
Price
$151.10
$7.47
Analyst Decision
Buy
Hold
Analyst Count
1
2
Target Price
$144.00
$10.15
AVG Volume (30 Days)
440.6K
550.5K
Earning Date
05-11-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
0.51
N/A
Revenue
$521,290,000.00
N/A
Revenue This Year
$8.61
$4.49
Revenue Next Year
$6.57
$6.42
P/E Ratio
$304.18
$18.67
Revenue Growth
35.49
N/A
52 Week Low
$98.27
$7.26
52 Week High
$171.85
$11.14

Technical Indicators

Market Signals
Indicator
NOVT
GRFS
Relative Strength Index (RSI) 46.82 41.33
Support Level $147.12 $7.38
Resistance Level $168.71 $8.88
Average True Range (ATR) 8.69 0.17
MACD -2.15 0.01
Stochastic Oscillator 8.18 24.69

Price Performance

Historical Comparison
NOVT
GRFS

About NOVT Novanta Inc.

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: